LIFE-BTK: Improving durability with bioresorbable technology

23

Speaking at TCT 2023 (23–26 October, San Francisco), vascular surgeon Ramon Varcoe (Sydney, Australia) reflects on the wider impact of the results of the LIFE-BTK trial on chronic limb-threatening ischaemia (CLTI) treatment.


LEAVE A REPLY

Please enter your comment!
Please enter your name here